Regent Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $11.5M | Sell |
101,451
-2,034
| -2% | -$231K | 3.09% | 5 |
|
|
2022
Q3 | $6.41M | Sell |
103,485
-1,690
| -2% | -$105K | 1.87% | 11 |
|
|
2022
Q2 | $8.39M | Buy |
105,175
+805
| +0.8% | +$64.2K | 2.34% | 7 |
|
|
2022
Q1 | $11M | Buy |
104,370
+307
| +0.3% | +$32.3K | 2.54% | 8 |
|
|
2021
Q4 | $11.2M | Buy |
104,063
+29
| +0% | +$3.13K | 2.44% | 8 |
|
|
2021
Q3 | $11.4M | Sell |
104,034
-5,765
| -5% | -$632K | 2.73% | 7 |
|
|
2021
Q2 | $10.3M | Sell |
109,799
-3,210
| -3% | -$301K | 2.41% | 8 |
|
|
2021
Q1 | $10.4M | Buy |
113,009
+514
| +0.5% | +$47.3K | 2.62% | 9 |
|
|
2020
Q4 | $8.23M | Sell |
112,495
-5,532
| -5% | -$405K | 2.28% | 9 |
|
|
2020
Q3 | $9.17M | Sell |
118,027
-6,666
| -5% | -$518K | 2.83% | 8 |
|
|
2020
Q2 | $6.93M | Sell |
124,693
-7,045
| -5% | -$392K | 2.3% | 9 |
|
|
2020
Q1 | $3.9M | Sell |
131,738
-810
| -0.6% | -$24K | 1.61% | 16 |
|
|
2019
Q4 | $4.8M | Buy |
132,548
+2,213
| +2% | +$80.1K | 1.47% | 18 |
|
|
2019
Q3 | $3.55M | Buy |
130,335
+1,225
| +0.9% | +$33.4K | 1.16% | 22 |
|
|
2019
Q2 | $3.11M | Buy |
129,110
+38,960
| +43% | +$937K | 1.01% | 29 |
|
|
2019
Q1 | $2.38M | Buy |
90,150
+37,660
| +72% | +$995K | 0.79% | 38 |
|
|
2018
Q4 | $1.03M | Buy |
52,490
+8,000
| +18% | +$156K | 0.38% | 76 |
|
|
2018
Q3 | $871K | Buy |
44,490
+7,400
| +20% | +$145K | 0.27% | 97 |
|
|
2018
Q2 | $614K | Sell |
37,090
-1,300
| -3% | -$21.5K | 0.21% | 112 |
|
|
2018
Q1 | $545K | Buy |
+38,390
| New | +$545K | 0.18% | 122 |
|